Operating income changed across a sign change
Operating income changed +190.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +190.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
R&D / revenue changed -273 basis points from the comparable as-filed period.
Cost of revenue changed +15.6% from the comparable as-filed period.
Working capital / assets changed +1421 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating cash-flow margin changed +293 basis points from the comparable as-filed period.
Receivables / revenue changed +1702 basis points from the comparable as-filed period.
Operating cash flow changed -6.5% from the comparable as-filed period.
Research & development changed -16.0% from the comparable as-filed period.
SBC / revenue changed -163 basis points from the comparable as-filed period.
Current ratio changed +22.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Net income changed +297.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Selling, general & administrative changed +11.3% from the comparable as-filed period.
Stock-based compensation changed -2.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.